A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of REGN475 in Patients with Pain Resulting from Thermal Injury

Grants and Contracts Details

StatusFinished
Effective start/end date3/8/10 → 7/31/10

Funding

  • i3 Research: $3,465.00